Melatonin is one of the most widely discussed supplements in the context of sleep, and interest in it tends to grow alongside the sleep changes that many women notice after 35. Understanding what melatonin actually does, how it changes with age, and what the research does and doesn’t support can help provide a more grounded basis for decisions about sleep management.
Melatonin is a hormone produced by the pineal gland in response to darkness, serving as a signal to the body that it is time to prepare for sleep. It does not induce sleep directly in the way a sedative medication might—rather, it shifts and reinforces the body’s internal clock (circadian rhythm). This distinction matters when evaluating both its effects and its appropriate use.
How Melatonin Production Changes After 35
Research indicates that melatonin production generally declines with age. Studies have found that older adults produce less melatonin overall and may experience a blunted nighttime peak compared to younger individuals. According to research cited by the Sleep Foundation, this age-related decline in melatonin may contribute to some of the sleep changes commonly observed in midlife—including difficulty falling asleep, earlier awakening, and lighter sleep overall.
In women specifically, hormonal fluctuations associated with perimenopause may also interact with melatonin rhythms. Some research suggests that estrogen and progesterone may influence melatonin receptor sensitivity, adding another layer of complexity to the relationship between hormonal change and sleep in women over 35. Individual variation in these interactions is considerable.
What the Research Shows About Melatonin Supplementation
Circadian Rhythm Disruption
The evidence base for melatonin supplementation is strongest in the context of circadian rhythm disruption—jet lag, shift work, and delayed sleep phase disorder. In these contexts, low-dose melatonin taken at the appropriate time can help shift the body’s internal clock and facilitate more timely sleep onset. This is a well-supported use, and the doses involved are typically lower (0.5–1 mg) than what is often available in commercial supplements.
General Insomnia and Sleep Maintenance
For general insomnia—difficulty falling or staying asleep unrelated to circadian misalignment—the evidence for melatonin is more mixed. Some meta-analyses suggest modest effects on sleep onset latency (the time it takes to fall asleep), but effects on sleep duration and quality are less consistent. For sleep maintenance difficulties (waking during the night), which are common during perimenopause, the evidence for standard melatonin supplementation is limited. For a broader discussion of evidence-based sleep strategies, see our complete guide to female sleep after 35.
Melatonin and Cognitive Behavioural Therapy for Insomnia (CBT-I)
Cognitive behavioural therapy for insomnia (CBT-I) is considered the first-line treatment for chronic insomnia by most sleep medicine guidelines—above pharmacological interventions including melatonin. CBT-I addresses the behavioural and cognitive factors that perpetuate insomnia and has a well-established evidence base for long-term improvement. If sleep difficulties are persistent and significantly affecting daily functioning, asking your healthcare provider about CBT-I as an option is worth considering.
Melatonin Use Considerations During Pregnancy and Trying to Conceive
For women who are pregnant or actively trying to conceive, the evidence on melatonin supplementation is insufficient to make confident safety recommendations. While some research has explored melatonin’s antioxidant properties and potential effects on oocyte quality, these studies are preliminary and do not provide a basis for routine supplementation in this context. If you are pregnant or trying to conceive and experiencing sleep difficulties, discussing safe management options with your healthcare provider or midwife is the most appropriate approach. Our article on sleep hygiene after 35 covers non-supplemental approaches that may be relevant.
Practical Considerations for Melatonin Use
If melatonin is something you are considering for sleep support, a few practical points are worth noting. Commercial supplements vary significantly in dose, and many contain amounts far higher than what research supports for sleep timing purposes. Starting with the lowest available dose (0.5–1 mg) rather than higher-dose formulations is generally aligned with current evidence. Timing also matters—taking melatonin 30–60 minutes before the desired sleep time tends to be more effective than taking it at or near the time of natural sleepiness. As with any supplement, discussing it with a healthcare provider before starting is advisable, particularly if you are taking other medications or have ongoing health conditions.
Frequently Asked Questions
Does melatonin really decline after 35?
Research does indicate that melatonin production generally decreases with age, though individual variation is significant and the decline is gradual rather than abrupt. Some studies suggest a more pronounced decline after midlife, though distinguishing age-related changes from other factors such as lifestyle, light exposure, and health conditions can be difficult in research settings.
What dose of melatonin is evidence-based?
Research suggests that low doses of melatonin—typically in the range of 0.5–1 mg—are sufficient for circadian rhythm purposes and may be more effective for sleep onset than the higher doses (3–10 mg) commonly found in commercial supplements. If using melatonin for sleep, starting with the lowest available dose is generally advisable, and discussing with a healthcare provider can help tailor recommendations to your situation.
Is melatonin safe to take every night?
Short-term use of melatonin appears to be generally well tolerated in adults. Evidence on long-term nightly use is more limited. Melatonin is not considered habit-forming in the way some sleep medications are, but dependence on it for sleep and potential effects on the body’s natural melatonin regulation with prolonged use are areas where more research is needed. Discussing ongoing use with a healthcare provider is advisable.
Can melatonin help with perimenopause-related sleep problems?
The evidence for melatonin specifically addressing perimenopause-related sleep disruption is limited. While some studies have explored melatonin’s effects in perimenopausal women, results are mixed and the effect sizes are often modest. If night sweats or hormonal fluctuations are the primary cause of sleep disruption, addressing those underlying factors—in discussion with a healthcare provider—may be more effective than melatonin alone.
Key Takeaways
- Melatonin production declines with age; this may contribute to some of the sleep changes women notice after 35, though individual variation is significant.
- Evidence for melatonin supplementation is strongest for circadian rhythm disruption (jet lag, shift work) and less robust for general insomnia or sleep maintenance.
- Low doses (0.5–1 mg) taken 30–60 minutes before the intended sleep time are more aligned with current research than the higher doses typically found in commercial products.
- CBT-I (cognitive behavioural therapy for insomnia) is considered the first-line treatment for chronic insomnia by sleep medicine guidelines and is worth asking about for persistent sleep difficulties.
- Women who are pregnant or trying to conceive should discuss sleep management options with their healthcare provider before using melatonin supplements.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.